Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Immunome Inc. Director's Dealing 2024

Jun 19, 2024

32238_dirs_2024-06-18_c63cce94-1848-466e-85e6-ce0982ac5ef9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2024-06-17

Reporting Person: Tsai Philip (N/A)

More from Immunome Inc.

Declaration of Voting Results & Voting Rights Announcements 2026
Jun 12
Annual Report 2026
Apr 24
Major Shareholding Notification 2026
Mar 26
Director's Dealing 2026
Mar 24
Regulatory Filings 2026
Mar 20
Annual Report 2026
Mar 3
Earnings Release 2026
Mar 3
Major Shareholding Notification 2026
Feb 17
Director's Dealing 2025
Dec 31
Director's Dealing 2025
Dec 23
View all filings →